Obinutuzumab in allogeneic transplantation for CLL and Richter’s transformation in the age of targeted therapies
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
Nov 12, 2021
|
| In: |
HemaSphere
Year: 2021, Jahrgang: 5, Heft: 12, Pages: 1-4 |
| ISSN: | 2572-9241 |
| DOI: | 10.1097/HS9.0000000000000664 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/HS9.0000000000000664 Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/hemasphere/Fulltext/2021/12000/Obinutuzumab_in_Allogeneic_Transplantation_for_CLL.2.aspx 
|
| Verfasserangaben: | Natali Pflug, Geothy Chakupurakal, Anna-Maria Fink, Sandra Robrecht, Marco Herling, Paula Cramer, Udo Holtick, Sebastian Theurich, Johannes Schetelig, Kirsten Fischer, Matthias Ritgen, Christof Scheid, Barbara Eichhorst, Peter Dreger, Michael Hallek, Michael von Bergwelt-Baildon, on behalf of the German CLL study group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1785191438 | ||
| 003 | DE-627 | ||
| 005 | 20220820102741.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220107s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/HS9.0000000000000664 |2 doi | |
| 035 | |a (DE-627)1785191438 | ||
| 035 | |a (DE-599)KXP1785191438 | ||
| 035 | |a (OCoLC)1341436793 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pflug, Natali |d 1980- |e VerfasserIn |0 (DE-588)142740306 |0 (DE-627)638925037 |0 (DE-576)333134567 |4 aut | |
| 245 | 1 | 0 | |a Obinutuzumab in allogeneic transplantation for CLL and Richter’s transformation in the age of targeted therapies |c Natali Pflug, Geothy Chakupurakal, Anna-Maria Fink, Sandra Robrecht, Marco Herling, Paula Cramer, Udo Holtick, Sebastian Theurich, Johannes Schetelig, Kirsten Fischer, Matthias Ritgen, Christof Scheid, Barbara Eichhorst, Peter Dreger, Michael Hallek, Michael von Bergwelt-Baildon, on behalf of the German CLL study group |
| 264 | 1 | |c Nov 12, 2021 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.01.2022 | ||
| 700 | 1 | |a Chakupurakal, Geothy |e VerfasserIn |0 (DE-588)111714397X |0 (DE-627)871266385 |0 (DE-576)478787804 |4 aut | |
| 700 | 1 | |a Fink, Anna-Maria |d 1960- |e VerfasserIn |0 (DE-588)131506528 |0 (DE-627)70764951X |0 (DE-576)298551934 |4 aut | |
| 700 | 1 | |a Robrecht, Sandra |e VerfasserIn |4 aut | |
| 700 | 1 | |a Herling, Marco |d 1973- |e VerfasserIn |0 (DE-588)12189102X |0 (DE-627)705691772 |0 (DE-576)292941242 |4 aut | |
| 700 | 1 | |a Cramer, Paula |d 1981- |e VerfasserIn |0 (DE-588)1011246384 |0 (DE-627)658059556 |0 (DE-576)341185671 |4 aut | |
| 700 | 1 | |a Holtick, Udo |d 1973- |e VerfasserIn |0 (DE-588)12908011X |0 (DE-627)388711388 |0 (DE-576)297483331 |4 aut | |
| 700 | 1 | |a Theurich, Sebastian |d 1976- |e VerfasserIn |0 (DE-588)132029154 |0 (DE-627)516850067 |0 (DE-576)298903350 |4 aut | |
| 700 | 1 | |a Schetelig, Johannes |d 1968- |e VerfasserIn |0 (DE-588)120026953 |0 (DE-627)696313138 |0 (DE-576)292002831 |4 aut | |
| 700 | 1 | |a Fischer, Kirsten |d 1973- |e VerfasserIn |0 (DE-588)132601230 |0 (DE-627)524413649 |0 (DE-576)299249794 |4 aut | |
| 700 | 1 | |a Ritgen, Matthias |d 1971- |e VerfasserIn |0 (DE-588)122069749 |0 (DE-627)081718217 |0 (DE-576)293076707 |4 aut | |
| 700 | 1 | |a Scheid, Christoph |e VerfasserIn |0 (DE-588)1075475244 |0 (DE-627)833299670 |0 (DE-576)443494495 |4 aut | |
| 700 | 1 | |a Eichhorst, Barbara |e VerfasserIn |0 (DE-588)1206419660 |0 (DE-627)169242260X |4 aut | |
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 700 | 1 | |a Hallek, Michael |e VerfasserIn |0 (DE-588)1167342933 |0 (DE-627)1031008063 |0 (DE-576)51110636X |4 aut | |
| 700 | 1 | |a Bergwelt, Michael von |e VerfasserIn |0 (DE-588)1206200111 |0 (DE-627)1691959790 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t HemaSphere |d Hoboken : John Wiley & Sons Ltd., 2017 |g 5(2021), 12, Artikel-ID e664, Seite 1-4 |h Online-Ressource |w (DE-627)1015324924 |w (DE-600)2922183-3 |w (DE-576)500571066 |x 2572-9241 |7 nnas |a Obinutuzumab in allogeneic transplantation for CLL and Richter’s transformation in the age of targeted therapies |
| 773 | 1 | 8 | |g volume:5 |g year:2021 |g number:12 |g elocationid:e664 |g pages:1-4 |g extent:4 |a Obinutuzumab in allogeneic transplantation for CLL and Richter’s transformation in the age of targeted therapies |
| 856 | 4 | 0 | |u https://doi.org/10.1097/HS9.0000000000000664 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://journals.lww.com/hemasphere/Fulltext/2021/12000/Obinutuzumab_in_Allogeneic_Transplantation_for_CLL.2.aspx |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220107 | ||
| 993 | |a Editorial | ||
| 994 | |a 2021 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 14 | ||
| 999 | |a KXP-PPN1785191438 |e 4030894542 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1785191438","note":["Gesehen am 07.01.2022"],"name":{"displayForm":["Natali Pflug, Geothy Chakupurakal, Anna-Maria Fink, Sandra Robrecht, Marco Herling, Paula Cramer, Udo Holtick, Sebastian Theurich, Johannes Schetelig, Kirsten Fischer, Matthias Ritgen, Christof Scheid, Barbara Eichhorst, Peter Dreger, Michael Hallek, Michael von Bergwelt-Baildon, on behalf of the German CLL study group"]},"relHost":[{"disp":"Obinutuzumab in allogeneic transplantation for CLL and Richter’s transformation in the age of targeted therapiesHemaSphere","pubHistory":["Volume 1, issue 1 (December 2017)-"],"note":["Gesehen am 18.01.2024"],"recId":"1015324924","origin":[{"publisher":"John Wiley & Sons Ltd. ; Wolters Kluwer Health","dateIssuedKey":"2024","publisherPlace":"Hoboken ; [Philadelphia, Pennsylvania]","dateIssuedDisp":"2024-"}],"corporate":[{"display":"European Hematology Association","role":"isb"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"issn":["2572-9241"],"zdb":["2922183-3"],"eki":["1015324924"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"HemaSphere","subtitle":"open access journal of the European Hematology Association","title_sort":"HemaSphere"}],"part":{"year":"2021","extent":"4","issue":"12","volume":"5","pages":"1-4","text":"5(2021), 12, Artikel-ID e664, Seite 1-4"}}],"person":[{"given":"Natali","family":"Pflug","display":"Pflug, Natali","role":"aut"},{"display":"Chakupurakal, Geothy","family":"Chakupurakal","given":"Geothy","role":"aut"},{"role":"aut","display":"Fink, Anna-Maria","family":"Fink","given":"Anna-Maria"},{"family":"Robrecht","display":"Robrecht, Sandra","given":"Sandra","role":"aut"},{"role":"aut","given":"Marco","family":"Herling","display":"Herling, Marco"},{"role":"aut","given":"Paula","family":"Cramer","display":"Cramer, Paula"},{"role":"aut","display":"Holtick, Udo","family":"Holtick","given":"Udo"},{"display":"Theurich, Sebastian","family":"Theurich","given":"Sebastian","role":"aut"},{"family":"Schetelig","display":"Schetelig, Johannes","given":"Johannes","role":"aut"},{"role":"aut","display":"Fischer, Kirsten","family":"Fischer","given":"Kirsten"},{"display":"Ritgen, Matthias","family":"Ritgen","given":"Matthias","role":"aut"},{"role":"aut","family":"Scheid","display":"Scheid, Christoph","given":"Christoph"},{"given":"Barbara","family":"Eichhorst","display":"Eichhorst, Barbara","role":"aut"},{"role":"aut","family":"Dreger","display":"Dreger, Peter","given":"Peter"},{"display":"Hallek, Michael","family":"Hallek","given":"Michael","role":"aut"},{"role":"aut","family":"Bergwelt","display":"Bergwelt, Michael von","given":"Michael von"}],"physDesc":[{"extent":"4 S."}],"title":[{"title_sort":"Obinutuzumab in allogeneic transplantation for CLL and Richter’s transformation in the age of targeted therapies","title":"Obinutuzumab in allogeneic transplantation for CLL and Richter’s transformation in the age of targeted therapies"}],"language":["eng"],"id":{"eki":["1785191438"],"doi":["10.1097/HS9.0000000000000664"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"Nov 12, 2021"}]} | ||
| SRT | |a PFLUGNATALOBINUTUZUM1220 | ||